09040

Cyber Savings Season: Get 30% off ACS membership with promo code CYBER24. Offer valid though Dec. 11.

Already an ACS Member? Log in here

Basic

$0 Community Associate

ACS’s Basic Package keeps you connected with C&EN and ACS.

JOIN NOW

Standard

$80 Regular Members & Society Affiliates

ACS’s Standard Package lets you stay up to date with C&EN, stay active in ACS, and save.

Eligibility restrictions apply. Review ACS Membership Packages to see if you qualify.

JOIN NOW

Premium

$160 Regular Members & Society Affiliates
$55 Graduate Students
$25 Undergraduate Students

ACS’s Premium Package gives you full access to C&EN and everything the ACS Community has to offer.

ACS offers discounts for some countries outside the United States. This discount is shown at checkout, if applicable.

JOIN NOW

« Prev

October 1, 2012 Cover

Volume 90, Issue 40

Finding new uses for approved drugs and shelved drug candidates is gaining steam as a pharmaceutical development strategy

Cover image:

Credit:

Full Article

Volume 90 | Issue 40

« Prev

Finding new uses for approved drugs and shelved drug candidates is gaining steam as a pharmaceutical development strategy

In covalent mechanochemistry, chemists are discovering new reactivity by subjecting molecules to mechanical force

European fine chemicals producers adapt big pharma factories to perform contract manufacturing work

Environment

‘Looper’

Sci-fi thriller provides a thought-provoking commentary on technology and time travel
Business

Pfizer’s Academic Experiment

The big pharma firm is banking on proximity to breed teamwork and ultimately improve the outcome of early-stage R&D
Environment

Talk, No Action On Nuclear Waste Plan

Time slips by as U.S. continues impasse over fate of spent fuel, radioactive nuclear waste
Sign up for C&EN must-read weekly newsletter

Email Address*

Contact us to opt out anytime